腦寧安 腦膜炎雙球菌四價接合型疫苗
Menveo Meningococcal Group A, C, W-135 and Y conjugate vaccine
主成分：Meningococcal group W-135 oligosaccharide Conjugated to Corynebacterium diphtheriae CRM197 protein、Meningococcal group A oligosaccharide Conjugated to Corynebacterium diphtheriae CRM197 protein、Meningococcal group Y oligosaccharide Conjugated to Corynebacterium diphtheriae CRM197 protein、Meningococcal group C oligosaccharide Conjugated to Corynebacterium diphtheriae CRM197 protein
J07AH08 meningococcus A,C,Y,W-135, tetravalent purified polysaccharides antigen conjugatedJ07AH02 other meningococcal monovalent purified polysaccharides antigenJ07AH07 meningococcus C, purified polysaccharides antigen conjugatedJ07AH10 meningococcus A, purified polysaccharides antigen conjugated
| 適應症 | Menveo 可用於幼童(2 歲及以上)、青少年與成人(≦55 歲)的主動免疫接種，以預防腦膜炎雙球菌(Neisseria meningitidis)血清型A、C、W-135與Y 所引起的侵入性疾病。 |
|---|---|
| 用法用量 | 請參照仿單說明。 |
| 劑型 | 注射用凍晶粉末與注射用液劑 |
| 藥品分級 | 處方藥（須由醫師處方） |
| 申請商 | 荷商葛蘭素史克藥廠股份有限公司台灣分公司 |
| 製造商 | PATHEON ITALIA S.P.A. |
| 有效日期 | 2031/09/23 |
| 許可證字號 | 衛部菌疫輸字第000968號 |
處方成分
- Meningococcal group A oligosaccharide Conjugated to Corynebacterium diphtheriae CRM197 proteinMeningococcal group A oligosaccharide......10 micrograms Conjugated to Corynebacterium diphtheriae CRM197 protein......16.7 to 33.3 micrograms
- Meningococcal group C oligosaccharide Conjugated to Corynebacterium diphtheriae CRM197 proteinMeningococcal group C oligosaccharide......5 micrograms Conjugated to Corynebacterium diphtheriae CRM197 protein......7.1 to 12.5 micrograms
- Meningococcal group W-135 oligosaccharide Conjugated to Corynebacterium diphtheriae CRM197 proteinMeningococcal group W-135 oligosaccharide......5 micrograms Conjugated to Corynebacterium diphtheriae CRM197 protein......3.3 to 8.3 micrograms
- Meningococcal group Y oligosaccharide Conjugated to Corynebacterium diphtheriae CRM197 proteinMeningococcal group Y oligosaccharide......5 micrograms Conjugated to Corynebacterium diphtheriae CRM197 protein......5.6 to 10.0 micrograms
點成分可查含相同成分的其他藥品。
含量數值依食藥署處方成分登錄，單位以仿單為準。
常見問題
腦寧安 腦膜炎雙球菌四價接合型疫苗是什麼藥？
腦寧安 腦膜炎雙球菌四價接合型疫苗是處方藥，主要成分為Meningococcal group A oligosaccharide Conjugated to Corynebacterium diphtheriae CRM197 protein、Meningococcal group C oligosaccharide Conjugated to Corynebacterium diphtheriae CRM197 protein、Meningococcal group W-135 oligosaccharide Conjugated to Corynebacterium diphtheriae CRM197 protein、Meningococcal group Y oligosaccharide Conjugated to Corynebacterium diphtheriae CRM197 protein，用於Menveo 可用於幼童(2 歲及以上)、青少年與成人(≦55 歲)的主動免疫接種，以預防腦膜炎雙球菌(Neisseri。
腦寧安 腦膜炎雙球菌四價接合型疫苗怎麼使用？
依食藥署核准用法用量：請參照仿單說明。。實際用法請依醫師、藥師指示與最新仿單。
腦寧安 腦膜炎雙球菌四價接合型疫苗有被回收嗎？
目前查無腦寧安 腦膜炎雙球菌四價接合型疫苗的回收紀錄。
相關工具
資料來源：衛生福利部食品藥物管理署 — 藥品許可證、藥品外觀、回收藥品、違規藥品廣告；中央健康保險署 — 健保用藥品項及藥價。最後更新：2026-06-15。